IV Tubing Sets and Accessories Market Size, Share, Growth, and Industry Analysis, By Type (Peripheral Intravenous Catheter Insertion, Central Venous Catheter Placement, PICC Line Insertion), By Application (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Skilled Nursing Facilities, Long Term Care Centers, Others), Regional Insights and Forecast to 2035

IV Tubing Sets and Accessories Market Overview

The global IV Tubing Sets and Accessories Market size estimated at USD 3226.15 million in 2026 and is projected to reach USD 4327.25 million by 2035, growing at a CAGR of 3.32% from 2026 to 2035.

The IV Tubing Sets and Accessories Market supports intravenous medication, fluid, nutrition, and bloodproduct delivery through primary sets, secondary sets, extension tubing, connectors, filters, stopcocks, clamps, and related components. In 2024, primary IV tubing sets represented 32.2% of product demand, while peripheral intravenous catheter insertion represented 48.5% of application demand. Hospitals accounted for 45.1% of enduse demand, reflecting intensive utilization across emergency care, surgery, oncology, intensive care, and inpatient therapy. North America held 46.9% of the global market in 2024. Increasing adoption of needlefree connectors, integrated filters, safety valves, nonDEHP materials, closed systems, and pumpcompatible administration sets continues to influence IV Tubing Sets and Accessories Market development.

The United States represents the largest national market for IV Tubing Sets and Accessories, supported by extensive hospital infrastructure, high utilization of infusion therapy, outpatient procedures, oncology treatment, critical care, and home infusion. North America accounted for 46.9% of global market share in 2024, with the United States representing the principal demand center. U.S. regulatory classification places intravascular administration sets, fluiddelivery tubing, extension tubing, and related components within Class II medicaldevice categories. The 2024 Baxter supply disruption also demonstrated the importance of domestic IVproduct manufacturing, while B. Braun increased IVset production capacity by more than 30 million units annually. Safety, interoperability, sterile packaging, and supply continuity remain key purchasing priorities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: A 46.9% North American share, 48.5% peripheral intravenous catheter application share, 45.1% hospital enduse share, and 32.2% primary tubing product share demonstrate the strong contribution of routine intravenous therapy, inpatient treatment, surgical procedures, and recurring disposabledevice consumption.

• Major Market Restraint: A 60% U.S. IVfluid production concentration at one major facility before the 2024 disruption, 100% dependence on sterile manufacturing for individual sets, and 1 contaminated connection potentially affecting an entire administration pathway highlight supplychain and infectioncontrol constraints.

• Emerging Trends: A 0.2micron inline filtration specification, 15micron airfilter capability, 20% U.S. IVsaline production increase by B. Braun in 2024, and 30millionplus additional annual IVset capacity demonstrate movement toward safer, integrated, highperformance infusion systems.

• Regional Leadership: A 46.9% North American share, 21.8% European share, 17.9% AsiaPacific share, and 8% Middle East and Africa share demonstrate North American leadership while highlighting significant adoption opportunities across European, Asian, Middle Eastern, and African healthcare systems.

• Competitive Landscape: Approximately 15% competitive supply share was attributed to B. Braun and approximately 14% to Baxter in one 2024 market assessment, while the broader competitive field contains 15 major manufacturers serving tubing, connectors, filters, infusion systems, and specialized administration applications.

• Market Segmentation: A 32.2% primaryIVtubing share, 48.5% peripheralcatheter application share, 21% PICCrelated demand estimate, and 45.1% hospital share indicate that standard tubing and peripheral access remain central to the market structure.

• Recent Development: A 20% B. Braun U.S. IVsaline production increase, 30millionplus additional IVset capacity, 2 channels on the Plum Duo platform, and 5 ICU Medical FDAcleared products during an 18month development period demonstrate accelerating infusionsystem modernization.

IV Tubing Sets and Accessories Market Latest Trends

The IV Tubing Sets and Accessories Market is increasingly shaped by patientsafety requirements, needlefree access, closed administration pathways, integrated filtration, and compatibility with electronic infusion pumps. In 2024, primary IV tubing sets held a 32.2% product share, confirming their importance in standard fluid and medication administration. Peripheral intravenous catheter insertion represented 48.5% of application demand, making peripheral access the largest procedurelinked segment. Hospitals accounted for 45.1% of enduse demand, reflecting high utilization in inpatient departments, emergency rooms, operating theaters, oncology units, and intensive care.

Material innovation is another important trend. Manufacturers increasingly offer PVC formulations without DEHP, polyurethane tubing, silicone pump segments, hydrophobic membranes, and integrated filters. A 0.2micron filter is used in selected administration configurations, while airmanagement features can incorporate filtration below 15 microns. Extension tubing is also becoming more important as home infusion and outpatient treatment expand. Needlefree connectors, antireflux designs, preassembled tubing, colorcoded pump segments, and closedsystem components are being incorporated to reduce connection steps and improve workflow. In 2024, B. Braun announced a 20% increase in U.S. IVsaline production and more than 30 million additional annual IVset production capacity, reinforcing the importance of supply resilience alongside product innovation.

IV Tubing Sets and Accessories Market Dynamics

The IV Tubing Sets and Accessories Market is influenced by clinical procedure volumes, hospital admissions, chronic disease treatment, infusionpump adoption, infectionprevention protocols, regulatory requirements, manufacturing capacity, and healthcare procurement practices. A 48.5% application share for peripheral intravenous catheter insertion demonstrates how routine vascular access creates recurring demand for compatible tubing and accessories. The 45.1% hospital enduse share also illustrates the importance of institutional healthcare settings.

DRIVER

Rising demand for intravenous therapies and peripheral vascular access.

The strongest market driver is the continued use of intravenous therapy across hospitals, emergency departments, surgical centers, oncology units, intensive care units, and outpatient treatment facilities. Peripheral intravenous catheter insertion represented 48.5% of application demand in 2024, making it the largest procedure category for the IV Tubing Sets and Accessories Market. Every peripheral access procedure can require compatible extension tubing, connectors, caps, clamps, and administration components depending on clinical protocol. Hospitals represented 45.1% of enduse demand, reinforcing the recurring consumption pattern created by high patient throughput. Chronic disease treatment also supports infusion demand because antibiotics, chemotherapy, hydration, analgesics, biologics, electrolytes, and parenteral nutrition frequently require controlled intravenous administration. 

RESTRAINT

Sterility requirements, supplychain concentration, and product standardization costs.

The IV Tubing Sets and Accessories Market faces significant constraints from sterile manufacturing requirements, qualitycontrol procedures, regulatory validation, rawmaterial availability, and supplychain concentration. Every administration set must meet strict requirements for material integrity, fluid compatibility, packaging, sterility, and mechanical performance. A single production disruption can affect large hospital networks because many facilities maintain standardized products across thousands of patientcare stations. The 2024 U.S. IVfluid disruption demonstrated this vulnerability when a major manufacturing facility responsible for approximately 60% of U.S. IVfluid supply was affected. B. Braun subsequently increased U.S. IVsaline production by 20% and expanded IVset production capacity by more than 30 million units annually.

OPPORTUNITY

Expansion of home infusion, outpatient treatment, and safetyengineered administration systems.

Home healthcare and outpatient infusion create substantial opportunities for IV Tubing Sets and Accessories Market manufacturers because therapy is increasingly moving beyond conventional inpatient environments. PICCrelated demand is particularly relevant because PICC systems can support prolonged antibiotic treatment, chemotherapy, nutrition, and other therapies. One industry estimate places PICCrelated demand at approximately 21%, illustrating the importance of longerduration vascular access to tubing and accessory consumption. Home settings require simplified connectors, lowdeadspace tubing, secure caps, extension lines, and easytooperate components. Manufacturers can also expand through preconfigured kits that combine tubing, connectors, filters, clamps, and protective components into standardized packages. Another opportunity involves nonPVC and nonDEHP materials, especially for sensitive medications and institutions with environmental or materialsafety policies.

CHALLENGE

Balancing infection prevention, device compatibility, cost efficiency, and supply reliability.

Manufacturers face the challenge of improving IVdevice safety without increasing complexity for clinicians or procurement teams. Each additional connector, filter, valve, or extension component can introduce another interface requiring validation, packaging, training, and quality control. Infection prevention remains critical because intravenous administration creates a direct pathway into the vascular system. Needlefree connectors and closedsystem configurations can reduce unnecessary exposure, but their performance depends on correct use and appropriate disinfection procedures. Device compatibility also presents a challenge because hospitals operate multiple infusion pumps, catheter platforms, and medicationdelivery systems. Manufacturers must therefore design tubing sets that perform consistently under gravity infusion and compatible pump conditions. 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

Segmentation Analysis

The IV Tubing Sets and Accessories Market is segmented by product configuration, vascularaccess application, and healthcare setting. Primary, secondary, extension, and accessory components address different infusion workflows, while peripheral intravenous catheter insertion, central venous catheter placement, and PICC line insertion define major application groups. In 2024, primary IV tubing sets represented 32.2% of product demand and peripheral intravenous catheter insertion represented 48.5% of application demand. Enduse demand was led by hospitals at 45.1%. Ambulatory surgical centers, specialized clinics, skilled nursing facilities, longterm care centers, and other healthcare settings contribute through procedurespecific and continuingcare requirements. These segments increasingly favor sterile, singleuse, safetyengineered, and pumpcompatible designs.

By Type

Peripheral Intravenous Catheter Insertion

Peripheral intravenous catheter insertion is the largest application segment in the IV Tubing Sets and Accessories Market, representing 48.5% of application demand in 2024. Its leading position is linked to widespread use in emergency departments, inpatient wards, surgical units, outpatient infusion facilities, and diagnostic procedures. Peripheral IV access commonly requires tubing or extension components that permit medication and fluid administration while maintaining a secure connection to the catheter. Needlefree connectors, clamps, injection ports, protective caps, and extension lines are increasingly integrated into standardized configurations. The high volume of peripheral access procedures creates recurring demand for disposable administration components. Product development is focused on reducing dead space, simplifying connections, improving flushing performance, preventing reflux, and reducing contamination opportunities.

Central Venous Catheter Placement

Central venous catheter placement represents a major specialized application because central access is used for critically ill patients, oncology therapies, longterm medication delivery, parenteral nutrition, and therapies requiring reliable vascular access. An indicative 30.5% share of procedurerelated demand places central venous catheter placement immediately behind peripheral access in the application structure. Central lines can involve multiple lumens, increasing the requirement for extension tubing, needlefree connectors, clamps, caps, and dedicated administration sets. Intensive care units and oncology centers are particularly important users because patients may receive several simultaneous medications or fluids. Product innovation focuses on reducing connection points, maintaining catheter patency, limiting contamination, and improving line organization. Central venous systems also require compatibility with pressure infusion, infusion pumps, and specialized filters where clinically appropriate.

By Application

Hospitals

Hospitals represent the largest enduse category, accounting for 45.1% of IV Tubing Sets and Accessories Market demand in 2024. High patient volumes, emergency treatment, surgery, intensive care, oncology, dialysisrelated therapy, and inpatient medication administration generate continuous consumption. Hospitals also require several tubing configurations because gravity infusion, pumpcontrolled infusion, bloodrelated administration, and secondary medication delivery can have different requirements. Procurement teams emphasize sterility, compatibility, standardized connectors, reliable supply, and product consistency. Large hospital systems may use thousands of individual administration components every month, making inventory management an important purchasing consideration. Infectioncontrol programs also encourage needlefree connectors, closed systems, and singleuse components. The hospital segment therefore remains the core commercial base for manufacturers offering comprehensive IV tubing portfolios.

Ambulatory Surgical Centers

Ambulatory surgical centers represent approximately 16% of enduse demand in an indicative 2024 segmentation profile. These facilities focus on procedures that allow patients to receive treatment without prolonged hospitalization, creating demand for efficient IV administration equipment. ASC users typically prioritize compact configurations, fast setup, standardized components, and reliable compatibility with infusion pumps used during anesthesia and recovery. Tubing sets can be configured for shortduration medication delivery, hydration, analgesics, antibiotics, and perioperative fluids. The shift toward minimally invasive procedures supports the importance of ASCs because shorter recovery periods can reduce inpatient utilization. Manufacturers have opportunities to develop procedurespecific kits containing tubing, connectors, caps, clamps, and related accessories. Such kits can reduce preparation steps and simplify inventory.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

IV Tubing Sets and Accessories Market Regional Outlook

Regional performance differs according to healthcare infrastructure, hospital capacity, regulatory standards, chronic disease burden, outpatient treatment, and medicaldevice manufacturing. North America held 46.9% of global market share in 2024, establishing clear regional leadership. Europe represented 21.8%, while AsiaPacific accounted for 17.9%. Middle East and Africa represented approximately 8%. Regional demand is increasingly influenced by infection prevention, infusionpump compatibility, hospital modernization, home healthcare, and supplychain resilience. North America remains technologyintensive, Europe emphasizes regulatory compliance and safety, AsiaPacific combines expanding healthcare access with manufacturing opportunities, and Middle East and Africa show growing demand from healthcare infrastructure investment.

North America

North America held 46.9% of the global IV Tubing Sets and Accessories Market in 2024, making it the leading regional market. The United States represents the principal demand center because of its extensive hospital network, high utilization of intravenous therapies, advanced infusion systems, and strong adoption of safetyengineered medical devices. Hospitals account for 45.1% of global enduse demand, and U.S. hospitals contribute substantially through emergency medicine, surgery, intensive care, oncology, and outpatient infusion. The region also has a strong installed base of infusion pumps, creating demand for compatible administration sets, pump segments, connectors, and extension tubing.Supply resilience became a major market issue in 2024. A major U.S. facility had previously supplied approximately 60% of domestic IV fluids before Hurricane Helene disrupted production. B. Braun responded by increasing U.S. IVsaline production by 20% and adding more than 30 million annual IVset production capacity. 

Europe

Europe accounted for 21.8% of global IV Tubing Sets and Accessories Market share in 2024, making it the secondlargest regional market. Germany, France, the United Kingdom, Italy, and other European healthcare systems provide established demand through hospitals, surgical centers, oncology facilities, and outpatient care. The region's aging population supports demand for chronic disease management, infusion therapy, and longterm medical treatment. European healthcare providers place strong emphasis on infection prevention, product traceability, material safety, and device compatibility.Manufacturers operating in Europe increasingly emphasize PVC alternatives, nonDEHP configurations, polyurethane tubing, needlefree connectors, hydrophobic membranes, and integrated filtration. Some administration sets incorporate 0.2micron filters for specific infusion applications, while airmanagement systems can use filtration below 15 microns.

AsiaPacific

AsiaPacific represented 17.9% of global IV Tubing Sets and Accessories Market share in 2024 and is becoming increasingly important because of healthcare infrastructure expansion, rising hospital capacity, growing procedure volumes, and broader access to infusion therapies. China, Japan, India, South Korea, Southeast Asia, and Australia form the principal regional demand centers. The region combines sophisticated healthcare systems with rapidly developing medical infrastructure, creating demand across both premium and costefficient IV administration products.China and India offer substantial opportunities because of large patient populations, expanding hospitals, and increasing healthcare investment. Japan provides a mature market with strong emphasis on precision, quality, infection prevention, and agingrelated healthcare needs. Southeast Asian markets are developing hospital capacity and expanding access to specialized treatments.

Middle East & Africa

The Middle East & Africa IV Tubing Sets and Accessories Market is supported by expanding hospital infrastructure, increasing surgical procedures, intensive-care capacity, and greater adoption of modern infusion-therapy systems. The region accounted for approximately 8% of the global IV Tubing Sets and Accessories Market in 2024. Saudi Arabia, the United Arab Emirates, South Africa, Egypt, and Qatar are important demand centers, with hospitals representing the principal end-use segment. Demand is concentrated around primary and secondary IV tubing sets, extension sets, needle-free connectors, filters, stopcocks, clamps, and pump-compatible administration sets. The Middle East benefits from investments in advanced hospitals and specialty-care facilities, while African markets increasingly require cost-efficient sterile disposable products.

List of Top IV Tubing Sets and Accessories Market Companies

• Poly Medicure
• Health Line International Corporation
• Zyno Medical
• R. Bard
• ICU Medical
• Dynarex
• Smiths Medical
• Nipro
• Vygon U.S.A
• Fresenius Kabi
• Perfect Medical
• Becton Dickinson and Company (CareFusion)
• Hospira (Pfizer)

List of Top tow Companies Market Share

• B Braun Melsungen — approximately 15%: Industry estimates place B. Braun at approximately 15% of competitive IV tubing and administrationset supply, supported by its broad infusion portfolio and substantial hospital presence. In 2024, the company increased U.S. IVsaline production by 20% and expanded annual IVset production capacity by more than 30 million units.

• Baxter International — approximately 14%: Baxter is estimated at approximately 14% of competitive IV tubing and administrationset supply, supported by its extensive IV therapy portfolio and hospital relationships. In 2024, its North Carolina facility had represented approximately 60% of U.S. IVfluid production before Hurricane Helene caused a major supply disruption.

Investment Analysis and Opportunities

Investment activity in the IV Tubing Sets and Accessories Market is increasingly directed toward manufacturing capacity, sterile production, automated assembly, quality systems, supplychain redundancy, and advanced safety components. The 2024 U.S. supply disruption demonstrated the strategic importance of geographically diversified production. B. Braun's 20% increase in U.S. IVsaline production and more than 30 million additional annual IVset capacity provide a clear example of capacityfocused investment. Manufacturers can also invest in automation because highvolume disposable devices require consistent dimensions, leak resistance, connector performance, and sterile packaging.

Another investment opportunity involves safetyengineered products. Needlefree connectors, antireflux valves, closed systems, integrated filters, and lowdeadspace components can command stronger institutional interest because they address infection prevention and medicationdelivery concerns. Home infusion provides another opportunity, particularly for extension tubing, compact administration sets, and caregiverfriendly connectors. AsiaPacific, with a 17.9% global share in 2024, offers opportunities for local manufacturing and distribution. Europe, with a 21.8% share, provides opportunities for advanced materials and sustainabilityfocused product development. North America remains the largest investment market at 46.9%, particularly for domestic manufacturing, automated production, and hospitalintegrated infusion technologies.

New Product Development

New product development in the IV Tubing Sets and Accessories Market is increasingly focused on safety, reduced dead space, better fluid management, material optimization, and integration with infusion pumps. B. Braun's administration systems demonstrate several development priorities, including AirStop filtration below 15 microns, PrimeStop protective caps, pumpcompatible tubing, and selected 0.2micron inline filters. These features are designed to improve fluidpath protection, reduce contamination opportunities, and simplify pump loading.

ICU Medical has also advanced infusion technology through its Plum platform. The Plum Duo system cleared by the FDA in 2023 incorporates 2 channels and 4 lines, while the 2025 Plum Solo and updated Plum Duo clearances expanded the company's precision IV platform. Such systems demonstrate the convergence of disposable administration sets, infusion pumps, safety software, and electronic healthrecord interoperability. Material development is another priority, with products using PVC without DEHP, polyurethane, silicone pump segments, and other material combinations. Manufacturers are also developing preconfigured tubing sets that reduce setup steps. Integrated connectors, clamps, filters, caps, and extension lines can reduce the number of individual components required during clinical preparation. These innovations are strengthening differentiation across the IV Tubing Sets and Accessories Market.

Five Recent Developments (20232025)

• August 2023: ICU Medical received FDA clearance for Plum Duo and LifeShield infusion safety software. The company received 510(k) clearance for the Plum Duo precision IV pump, designed with 2 channels and 4 lines, a 10inch fullcolor touchscreen, an inline air trap, and PlumSet administration cassettes featuring needlefree connectors. The development strengthened ICU Medical's broader IV delivery platform and supported planned U.S. availability in 2024.
• October 2024: B. Braun announced increased U.S. IV production capacity. The company increased IVsaline production by 20% at facilities in California and Florida and planned to add more than 30 million IV sets to annual production capacity. The initiative also expanded output of valves and connectors used in infusion therapy, strengthening domestic supply resilience following the 2024 U.S. IVfluid shortage.
• October 2024: Baxter expanded international IVproduct supply to the United States. Following Hurricane Helene's disruption of its North Carolina facility, Baxter planned to import 18,000 tons of IV products from international manufacturing facilities by the end of 2024. U.S. regulatory authorities temporarily authorized imports from 5 facilities in Canada, China, Ireland, and the United Kingdom to support continuity of IVproduct availability.
• October 2024: Fresenius Kabi accelerated infusionsolution production planning in the United States. The company evaluated options to accelerate additional production capacity at its North Carolina operations after the Baxter disruption. The initiative supported broader availability of intravenous solutions and reinforced the strategic importance of domestic infusionproduct manufacturing, particularly for hospitals dependent on continuous supplies of IV therapy products.
• April 2025: ICU Medical introduced Plum Solo and expanded the Plum Duo precision IV platform. The company received 510(k) clearances for the Plum Solo singlechannel pump and updated Plum Duo system, expanding its IV Performance Platform. The 2025 development added 7inch and 10inch touchscreen configurations, centralized druglibrary management, LifeShield connectivity, and IVEHR interoperability capabilities.

Report Coverage of IV Tubing Sets and Accessories Market

The IV Tubing Sets and Accessories Market report covers product structures, application categories, healthcare settings, regional performance, competitive positioning, technology trends, investment opportunities, and manufacturer developments. Product analysis includes primary IV tubing sets, secondary IV tubing sets, extension IV tubing sets, and IV tubing accessories. Application analysis includes peripheral intravenous catheter insertion, central venous catheter placement, and PICC line insertion. Enduse analysis covers hospitals, ambulatory surgical centers, specialized clinics, skilled nursing facilities, longterm care centers, and other healthcare environments.

The regional assessment covers North America, Europe, AsiaPacific, and Middle East and Africa, with specific attention to marketshare indicators such as 46.9% for North America, 21.8% for Europe, 17.9% for AsiaPacific, and approximately 8% for Middle East and Africa in 2024. Competitive coverage includes 15 major companies, including Baxter International, B. Braun Melsungen, ICU Medical, Fresenius Kabi, Becton Dickinson, Nipro, Poly Medicure, Vygon U.S.A., and other established manufacturers. The report also examines safetyengineered connectors, integrated filters, nonDEHP materials, needlefree technologies, pumpcompatible administration sets, supplychain resilience, manufacturing capacity, and recent product developments recorded during 2023, 2024, and 2025.

IV Tubing Sets and Accessories Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3226.15 Million in 2026
Market Size Value By	USD 4327.25 Million by 2035
Growth Rate	CAGR of 3.32% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Peripheral Intravenous Catheter Insertion Central Venous Catheter Placement PICC Line Insertion By Application : Hospitals Ambulatory Surgical Centers Specialized Clinics Skilled Nursing Facilities Long Term Care Centers Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample